Therapeutics announced that the first patient has been dosed in a Phase 2 clinical trial of praliciguat, an oral, once-daily ...
The treatment of male erectile dysfunction (MED) has evolved during the last decade from surgical options or intracavernosal–intraurethral injections to the recent development of oral therapies such ...
Soluble guanylate cyclase (sGC) activator is being studied in patients with chronic kidney disease (CKD), with potential implications for cardiovascular disease treatment CKD is a progressive ...
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics ...
The soluble guanylate cyclase activator runcaciguat significantly improved albuminuria in patients with CKD on top of RAS inhibitor and SGLT2 inhibitor treatment. Runcaciguat, an oral soluble ...
Mayo Foundation for Medical Education and Research (MFMER) and University of Florida have identified atrial natriuretic peptide B (NPR2; guanylate cyclase B) receptor positive allosteric modulators ...
(RTTNews) - Merck & Co Inc. (MRK) said Wednesday that the U.S. Food and Drug Administration has approved Verquvo, a soluble guanylate cyclase stimulator, to reduce the risk of cardiovascular death and ...
While you may have heard of monosodium glutamate (MSG), disodium guanylate is another food additive that has likely flown under your radar. This is perfectly understandable, as it’s sometimes listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback